SEC Form 4 · accession 0001645627-17-000142
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 21, 2017
Accepted (ET)
Nov 28, 2017 · 11:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 21, 2017 | P | 3,000 | $0.0575 | A | 24,255,189 | D | |
| Common Stock | Nov 21, 2017 | P | 3,000 | $0.056 | A | 24,258,189 | D | |
| Common Stock | Nov 21, 2017 | P | 3,000 | $0.0546 | A | 24,261,189 | D | |
| Common Stock | Nov 22, 2017 | P | 1,380 | $0.0605 | A | 24,262,569 | D | |
| Common Stock | Nov 22, 2017 | P | 1,620 | $0.061 | A | 24,264,189 | D | |
| Common Stock | Nov 24, 2017 | P | 3,000 | $0.0614 | A | 24,267,189 | D | |
| Common Stock | Nov 24, 2017 | P | 3,000 | $0.065 | A | 24,270,189 | D | |
| Common Stock | Nov 24, 2017 | P | 3,000 | $0.0654 | A | 24,273,189 | D |
Table II — derivative securities
No Table II lines on this filing.